Cargando…

Identification and Validation of METTL3-Related Molecules for Predicting Prognosis and Efficacy of Immunotherapy in Gastric Cancer Based on m6A Methylome and Transcriptome Sequencing Analysis

Abnormal N6-methyladenosine (m6A) modification levels caused by METTL3 have been identified to be a critical regulator in human cancers, and its roles in the immune microenvironment and the relationship between targeted therapy and immunotherapy sensitivity in gastric cancer (GC) remain poorly under...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Shuran, Su, Xu, Wang, Jing, Zheng, Ni, Tang, Yuan, Peng, Guisen, Dong, Rui, Lu, Fei, Liu, Mulin, Zhao, Yunli, Wu, Huazhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373839/ https://www.ncbi.nlm.nih.gov/pubmed/35965524 http://dx.doi.org/10.3389/fonc.2022.935239

Ejemplares similares

Integrative proteomics and m6A microarray analyses of the signatures induced by METTL3 reveals prognostically significant in gastric cancer by affecting cellular metabolism
por: Peng, Guisen, et al.
Publicado: (2022)

Models for Predicting Response to Immunotherapy and Prognosis in Patients with Gastric Cancer: DNA Damage Response Genes
por: Dong, Rui, et al.
Publicado: (2022)

m(7)G-Related DNA Damage Repair Genes are Potential Biomarkers for Predicting Prognosis and Immunotherapy Effectiveness in Colon Cancer Patients
por: Chen, Shuran, et al.
Publicado: (2022)

Therapeutic effect and transcriptome-methylome characteristics of METTL3 inhibition in liver hepatocellular carcinoma
por: Liu, Qingbin, et al.
Publicado: (2023)

METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway
por: Yang, Dong-Dong, et al.
Publicado: (2020)

Comprehensive analysis of the significance of METTL7A gene in the prognosis of lung adenocarcinoma
por: Pan, Ya-Qiang, et al.
Publicado: (2022)

GPC1 promotes the growth and migration of colorectal cancer cells through regulating the TGF-β1/SMAD2 signaling pathway
por: Lu, Fei, et al.
Publicado: (2022)

METTL3 Is Associated With the Malignancy of Esophageal Squamous Cell Carcinoma and Serves as a Potential Immunotherapy Biomarker
por: Zhou, Yubin, et al.
Publicado: (2022)

METTL3-Mediated ADAMTS9 Suppression Facilitates Angiogenesis and Carcinogenesis in Gastric Cancer
por: Wang, Nuofan, et al.
Publicado: (2022)

Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma
por: Li, Tian-Hao, et al.
Publicado: (2021)

High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in Glioma
por: Xiong, Yujia, et al.
Publicado: (2021)

Transcriptome-Wide Map of N(6)-Methyladenosine Methylome Profiling in Human Bladder Cancer
por: Li, Aolin, et al.
Publicado: (2021)

Comprehensive Analysis of the Transcriptome-Wide m6A Methylome in Endometrioid Ovarian Cancer
por: Yang, Li, et al.
Publicado: (2022)

The value of metabolic LncRNAs in predicting prognosis and immunotherapy efficacy of gastric cancer
por: Du, Peizhun, et al.
Publicado: (2023)

Differences in genome, transcriptome, miRNAome, and methylome in synchronous and metachronous liver metastasis of colorectal cancer
por: Horak, Josef, et al.
Publicado: (2023)

Comprehensive Analysis of the Transcriptome-wide m6A Methylome in Lung Adenocarcinoma by MeRIP Sequencing
por: Mao, Wenli, et al.
Publicado: (2022)

Corrigendum: Comprehensive analysis of the transcriptome-wide m6A methylome in lung adenocarcinoma by MeRIP sequencing
por: Mao, Wenli, et al.
Publicado: (2022)

Establishment and validation of a ferroptosis-related signature predicting prognosis and immunotherapy effect in colon cancer
por: Li, Zhufeng, et al.
Publicado: (2023)

The Role of RNA Methyltransferase METTL3 in Normal and Malignant Hematopoiesis
por: Wu, Xia, et al.
Publicado: (2022)

Dissecting the effects of METTL3 on alternative splicing in prostate cancer
por: Wang, Lin, et al.
Publicado: (2023)

Development and validation of an inflammatory response-related signature in triple negative breast cancer for predicting prognosis and immunotherapy
por: Guo, Yangyang, et al.
Publicado: (2023)

Multiple Functions and Mechanisms Underlying the Role of METTL3 in Human Cancers
por: Zheng, Wenhui, et al.
Publicado: (2019)

Machine learning identifies characteristics molecules of cancer associated fibroblasts significantly correlated with the prognosis, immunotherapy response and immune microenvironment in lung adenocarcinoma
por: Wang, Qian, et al.
Publicado: (2022)

Construction and Validation of Convenient Clinicopathologic Signatures for Predicting the Prognosis of Stage I-III Gastric Cancer
por: You, Weiqiang, et al.
Publicado: (2022)

Identification and validation of a novel angiogenesis-related gene signature for predicting prognosis in gastric adenocarcinoma
por: Xu, Peipei, et al.
Publicado: (2023)

METTL3 Is Suppressed by Circular RNA circMETTL3/miR-34c-3p Signaling and Limits the Tumor Growth and Metastasis in Triple Negative Breast Cancer
por: Ruan, Han-guang, et al.
Publicado: (2021)

Downregulation of Long Non-coding RNA FALEC Inhibits Gastric Cancer Cell Migration and Invasion Through Impairing ECM1 Expression by Exerting Its Enhancer-Like Function
por: Wu, Huazhang, et al.
Publicado: (2019)

Identification of gene signatures related to hypoxia and angiogenesis in pancreatic cancer to aid immunotherapy and prognosis
por: Li, Xiushen, et al.
Publicado: (2023)

LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer
por: Song, Zhengwei, et al.
Publicado: (2022)

Identification and Validation of Immune-Related Long Non-Coding RNA Signature for Predicting Immunotherapeutic Response and Prognosis in NSCLC Patients Treated With Immunotherapy
por: Ma, Jianli, et al.
Publicado: (2022)

Cancer Stemness Associated With Prognosis and the Efficacy of Immunotherapy in Adrenocortical Carcinoma
por: Shi, Xiaoxi, et al.
Publicado: (2021)

Impact of cytotoxic T lymphocytes immunotherapy on prognosis of colorectal cancer patients
por: Zhu, Yankun, et al.
Publicado: (2023)

The Comprehensive Analysis of N6-Methyadenosine Writer METTL3 and METTL14 in Gastric Cancer
por: Ge, Yiling, et al.
Publicado: (2023)

Identification and validation of signature for prognosis and immune microenvironment in gastric cancer based on m6A demethylase ALKBH5
por: Ji, Tiannan, et al.
Publicado: (2023)

ERCC1 is a potential biomarker for predicting prognosis, immunotherapy, chemotherapy efficacy, and expression validation in HER2 over-expressing breast cancer
por: Li, Yilun, et al.
Publicado: (2022)

Evaluation of circulating tumor DNA by electropherogram analysis and methylome profiling in high-risk neuroblastomas
por: Trinidad, Eva María, et al.
Publicado: (2023)

Transcriptome-wide m(6)A methylome analysis uncovered the changes of m(6)A modification in oral pre-malignant cells compared with normal oral epithelial cells
por: Chen, Xun, et al.
Publicado: (2022)

Establishment and validation of a clinicopathological prognosis model of gastroenteropancreatic neuroendocrine carcinomas
por: Chen, Jing, et al.
Publicado: (2022)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

Would the Addition of Immunotherapy Impact the Prognosis of Patients With Malignant Pericardial Effusion?
por: Chiruvella, Varsha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ihjgr5d4qt83i69af1186eio14